BlackRock Health Sciences Trust (NYSE:BME – Get Free Report) saw a large decrease in short interest in the month of November. As of November 30th, there was short interest totalling 6,200 shares, a decrease of 56.0% from the November 15th total of 14,100 shares. Based on an average daily volume of 38,100 shares, the days-to-cover ratio is presently 0.2 days.
Institutional Investors Weigh In On BlackRock Health Sciences Trust
A number of large investors have recently modified their holdings of BME. Fountainhead AM LLC acquired a new stake in BlackRock Health Sciences Trust during the third quarter worth about $204,000. Calamos Advisors LLC increased its holdings in shares of BlackRock Health Sciences Trust by 46.4% during the 2nd quarter. Calamos Advisors LLC now owns 7,884 shares of the company’s stock worth $322,000 after buying an additional 2,500 shares during the last quarter. City of London Investment Management Co. Ltd. purchased a new stake in shares of BlackRock Health Sciences Trust during the 2nd quarter valued at approximately $429,000. Logan Stone Capital LLC acquired a new position in BlackRock Health Sciences Trust in the second quarter valued at approximately $600,000. Finally, Raymond James Trust N.A. grew its position in BlackRock Health Sciences Trust by 8.1% in the second quarter. Raymond James Trust N.A. now owns 22,036 shares of the company’s stock worth $900,000 after acquiring an additional 1,649 shares during the period.
BlackRock Health Sciences Trust Stock Performance
BlackRock Health Sciences Trust stock opened at $38.68 on Friday. BlackRock Health Sciences Trust has a 12 month low of $38.00 and a 12 month high of $42.86. The business has a 50 day simple moving average of $40.31 and a 200-day simple moving average of $40.84.
BlackRock Health Sciences Trust Announces Dividend
BlackRock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Featured Stories
- Five stocks we like better than BlackRock Health Sciences Trust
- Retail Stocks Investing, Explained
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Industrial Products Stocks Investing
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.